IMCR Financials

Immunocore Holdings Ltd - Financial statements & key metrics

Stock Price

$36.86

Market Cap

$1.45B

P/E Ratio

-36.1

EPS

$-0.58

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$310.20M

Gross Profit

Operating Income

Net Income

$-51.09M

EPS (Diluted)

$-1.02

Balance Sheet Highlights

Total Assets

$1.01B

Total Liabilities

$648.79M

Shareholders Equity

Cash & Equivalents

$455.73M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$26.06M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-6.9%

Net Margin

-7.7%

ROE

-7.5%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IMCR revenue?

IMCR's most recent quarterly revenue was $310.20M. Annual revenue can be calculated by summing the four most recent quarters.

Is IMCR profitable?

IMCR reported a loss of $51.09M in the most recent quarter. The net profit margin is -7.7%.

What is IMCR market cap?

IMCR has a market capitalization of $1.45B, making it a small-cap stock.

Does IMCR have debt?

View IMCR's balance sheet for debt information.

What is IMCR cash flow?

Cash flow data is available in the full financial statements.